REVIVA PHARMACEUTICALS HOLDINGS, INC. financial data

Symbol
RVPH on Nasdaq
Location
Cupertino, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 94% %
Debt-to-equity 10855% %
Return On Assets -188% % 25%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 115,058,619 shares 244%
Common Stock, Shares, Outstanding 96,337,119 shares 188%
Entity Public Float $31,800,000 USD
Common Stock, Value, Issued $9,618 USD 188%
Weighted Average Number of Shares Outstanding, Basic 72,685,740 shares 115%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $14,650,607 USD -44%
General and Administrative Expense $8,274,989 USD 6.1%
Operating Income (Loss) $22,925,596 USD 33%
Nonoperating Income (Expense) $189,636 USD -83%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $22,735,960 USD 31%
Income Tax Expense (Benefit) $20,740 USD 103%
Net Income (Loss) Attributable to Parent $22,756,700 USD 31%
Earnings Per Share, Basic 0 USD/shares 59%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $13,183,259 USD 137%
Assets, Current $13,512,928 USD 98%
Assets $14,332,649 USD 88%
Accounts Payable, Current $5,431,806 USD -38%
Employee-related Liabilities, Current $784,956 USD -11%
Liabilities, Current $9,738,408 USD -44%
Liabilities $9,782,914 USD -44%
Retained Earnings (Accumulated Deficit) $180,770,273 USD -14%
Stockholders' Equity Attributable to Parent $4,549,735 USD
Liabilities and Equity $14,332,649 USD 88%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $8,194,198 USD 30%
Net Cash Provided by (Used in) Financing Activities $7,271 USD -98%
Common Stock, Shares Authorized 315,000,000 shares 174%
Common Stock, Shares, Issued 96,337,119 shares 188%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities $10,158 USD 191%
Deferred Tax Assets, Valuation Allowance $31,488,340 USD 15%
Deferred Tax Assets, Gross $31,488,340 USD 15%
Depreciation $0 USD
Deferred Tax Assets, Operating Loss Carryforwards $15,687,479 USD 2.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $1,704,925 USD 112%
Additional Paid in Capital $185,310,390 USD 25%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $2,326,992 USD 59%
Interest Expense $3,487 USD -54%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%